Article
Resiquimod-encapsulated MOF525 for Sustained Immunostimulant Release and Synergistic Photodynamic– Immunotherapy in Colorectal Cancer
2026-01-14
Abstract excerpt
<title>Abstract</title> <p> Metal-organic frameworks (MOFs) represent a novel class of materials with exceptional potential for biomedical applications. In this study, we present MOF525, a porphyrin-based MOF, as a dual-functional platform for photodynamic therapy (PDT) and immunotherapy in the treatment of colorectal cancer. MOF525 encapsulates Resiquimod (R848), a potent Toll-like receptor 7/8 agonist, thereby...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4a897c51-dbe7-5ede-83ca-80bb0ceccff5
- DOI
- 10.21203/rs.3.rs-8452162/v1
